Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2017 1
2018 1
2019 1
2020 2
2021 2
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
The Male Reproductive System and Endocrine Disruptors.
Schiesaro MG, Amato AML, Maneschi C, Sciabica V, Pigatto E, Sanna M. Schiesaro MG, et al. Among authors: amato aml. Endocr Metab Immune Disord Drug Targets. 2022 Aug 15;22(7):686-703. doi: 10.2174/1871530321666211004100633. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 34607552
Gynecomastia in subjects with sexual dysfunction.
Maseroli E, Rastrelli G, Corona G, Boddi V, Amato AM, Mannucci E, Forti G, Maggi M. Maseroli E, et al. J Endocrinol Invest. 2014 Jun;37(6):525-32. doi: 10.1007/s40618-014-0055-z. Epub 2014 Feb 11. J Endocrinol Invest. 2014. PMID: 24515298
Comparing the accuracy of transcutaneous sensor and 90-day implantable glucose sensor.
Boscari F, Vettoretti M, Amato AML, Vallone V, Uliana A, Iori E, Avogaro A, Facchinetti A, Bruttomesso D. Boscari F, et al. Among authors: amato aml. Nutr Metab Cardiovasc Dis. 2021 Feb 8;31(2):650-657. doi: 10.1016/j.numecd.2020.09.006. Epub 2020 Sep 12. Nutr Metab Cardiovasc Dis. 2021. PMID: 33594987 Clinical Trial.
Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance.
Boscari F, Vettoretti M, Cavallin F, Amato AML, Uliana A, Vallone V, Avogaro A, Facchinetti A, Bruttomesso D. Boscari F, et al. Among authors: amato aml. J Endocrinol Invest. 2022 Jan;45(1):115-124. doi: 10.1007/s40618-021-01624-2. Epub 2021 Jul 1. J Endocrinol Invest. 2022. PMID: 34196924 Free PMC article. Clinical Trial.
Performance of the Steno type 1 risk engine for cardiovascular disease prediction in Italian patients with type 1 diabetes.
Boscari F, Morieri ML, Amato AML, Vallone V, Uliana A, Baritussio A, Vitturi N, Cipponeri E, Cavallin F, Avogaro A, Fadini GP, Bruttomesso D. Boscari F, et al. Among authors: amato aml. Nutr Metab Cardiovasc Dis. 2020 Sep 24;30(10):1813-1819. doi: 10.1016/j.numecd.2020.07.006. Epub 2020 Jul 11. Nutr Metab Cardiovasc Dis. 2020. PMID: 32807633
FreeStyle Libre and Dexcom G4 Platinum sensors: Accuracy comparisons during two weeks of home use and use during experimentally induced glucose excursions.
Boscari F, Galasso S, Facchinetti A, Marescotti MC, Vallone V, Amato AML, Avogaro A, Bruttomesso D. Boscari F, et al. Among authors: amato aml. Nutr Metab Cardiovasc Dis. 2018 Feb;28(2):180-186. doi: 10.1016/j.numecd.2017.10.023. Epub 2017 Nov 11. Nutr Metab Cardiovasc Dis. 2018. PMID: 29258716 Clinical Trial.